Amgen VP has 68 shares withheld for taxes
Amgen Inc. vice president, finance and chief accounting officer Matthew C. Busch reported routine share dispositions related to tax withholding.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Amgen Inc. vice president, finance and chief accounting officer Matthew C. Busch reported routine share dispositions related to tax withholding. On May 2, 2026, a total of 68 shares of common stock were withheld at $329.82 per share to satisfy tax obligations tied to equity awards.
Following these transactions, Busch directly holds 3,980 shares of Amgen common stock. A footnote explains that his holdings include 49 Dividend Equivalents linked to unvested Restricted Stock Units, which will be settled in common shares as those units vest.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 30 | $329.82 | $10K |
| Exercise Price or Tax Liability | Common Stock | 38 | $329.82 | $13K |
Footnotes (1)
- F1. These shares include 49 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Key Figures
Key Terms
tax-withholding disposition financial
Dividend Equivalents financial
Restricted Stock Units financial
Equity Incentive Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did Amgen (AMGN) report for Matthew C. Busch?
What are Dividend Equivalents mentioned in Matthew C. Busch’s Amgen filing?
Were Matthew C. Busch’s Amgen transactions open-market sales or tax withholding?
AI-generated analysis. How Rhea-AI works. Not financial advice.